Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

Hepatology

Volumn 24, Issue 5, 1996, Pages 1068-1073

  Czaja, Albert J ^a,c   Cassani, Fabio ^b   Cataleta, Michela ^b   Valentini, Paolo ^b   Bianchi, Francesco B ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN ANTIBODY; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; HLA A1 ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN; PREDNISONE; SMOOTH MUSCLE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0029961272     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008903377     Document Type: Article

References (39)

1. Mackay IR. Immunological aspects of chronic active hepatitis. HEPATOLOGY 1983;3:724-728.
2. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
3. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, et al. Meeting Report. International Autoimmune Hepatitis Group. HEPATOLOGY 1993;18:998-1005.
4. Toh BH. Smooth muscles autoantibodies and autoantigens. Clin Exp Immunol 1979;38:621-628.
5. Whittingham S, McNeilage LJ. Antinuclear antibodies as molecular and diagnostic probes. Mol Cell Probes 1988;2:169-179.
6. Tan EM, Chan EKL, Sullivan KF, Rubin RL. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988;47:121-141.
7. Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical revelance. Semin Liver Dis 1991;11:205-214.
8. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 1983;85:713-717.
9. Czaja AJ. Autoimmune chronic active hepatitis - a specific entity? The negative argument. J Gastroenterol Hepatol 1990;5:343-351.
10. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994;107:200-207.
11. Czaja AJ, Ming C, Shirai M, Nishioka M. Frequency and significance of antibodies to histones in autoimmune hepatitis. J Hepatol 1995;23:32-38.
12. Lidman K, Biberfield G, Fagraeus A, Norberg R, Tortensson R, Utter G, Carlsson L, et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 1976;24:266-272.
13. Kurki P, Miettinen A, Linder E, Pikkarainen P, Vuoristo M, SalasPuro MP. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance. Gut 1980;21:878-884.
14. Kurki P, Miettinen A, Salaspuro M, Virtanen I, Stenman S. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. HEPATOLOGY 1983;3:297-302.
15. Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, Bianchi FB. Anti-actin antibodies: a new test for an old problem? J Immunol Methods 1990;130:1-8.
16. Homberg J-C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. HEPATOLOGY 1987;7:1333-1339.
17. Bretherton L, Brown C, Pedersen JS, Toh B-H, Clarke FM, Mackay IR, Gust ID. ELISA assay for IgG autoantibody to actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983;51:611-616.
18. Pedersen JS, Toh BH, Mackay IR, Tait BD, Gust ID, Kastelan A, Hadzic N. Segegation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol 1982;48:527-532.
19. Cunningham AL, Mackay IR, Frazer IH, Brown C, Pedersen JS, Toh B-H, Tait BD, et al. Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol 1985;34:158-164.
20. Dighiero G, Lymberi P, Monot C, Abuaf N. Sera with high levels of antismooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeletal proteins. Clin Exp Immunol 1990;82:52-56.
21. Maddrey WC. Subdivisions of idiopathic autoimmune chronic active hepatitis. HEPATOLOGY 1987;7:1372-1375.
22. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis - a point of view. Am J Gastroenterol 1995;90:1206-1211.
23. Czaja AJ. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-456.
24. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. HEPATOLOGY 1990;13:701-706.
25. Doherty DG, Donaldson PT, Underbill JA, Farrant JM, Duthie A, Mieli-Vergani G, McFarlane IG, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. HEPATOLOGY 1994;19:609-615.
26. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993;105:1502-1507.
27. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. HEPATOLOGY 1993;18:816-822.
28. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-1295.
29. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VLW, Aamodt R. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 1989;64:1226-1234.
30. Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence. J Clin Pathol 1976;29:403-410.
31. Cassani F, Fusconi M, Bianchi FB, Selleri L, Baffoni L, Lenzi M, Pisi E. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol 1987;68:588-595.
32. Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantibody profile in primary sclerosing cholangitis. J Hepatol 1987;5:14-18.
33. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, Zauli D. Impact of International Autoimmune Hepatitis Group Scoring System in definition of autoimmune hepatitis: an Italian experience. Dig Dis Sci 1996;41:166-171.
34. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-1832.
35. Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. HEPATOLOGY 1984;4:622-627.
36. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1975;20:1087-1090.
37. Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT, Bradley BA. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including Drw10. Transplantation 1988;45:640-646.
38. Mackay IR, Tait BD. HLA associations with autoimmune-type chronic active hepatitis: identification of BS-DRw3 haplotype by family studies. Gastroenterology 1980;79:95-98.
39. Czaja AJ, Rakela J, Hay JE, Moore SB. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1990;98:1587-1593.